Tonix Pharmaceuticals Quote - TNXP

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.50

Bid

0.50

Offer

0.509

Volume

14,492,190

0.00 Day's Range 0.00

0.118 52 Week Range 14.08

Market Cap

93.447M

Previous Close

0.6116

Open

Last Trade

145

0.5

(formt)

Last Trade Time

00:18:40

Financial Volume

VWAP

Average Volume (3m)

92,341,699

Shares Outstanding

186,894,225

Dividend Yield

PE Ratio

-0.98

Earnings Per Share (EPS)

-0.62

Revenue

7.77M

Net Profit

-116.66M

Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio is composed of immunology, rare disease, infectious dise... Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio is composed of immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. Tonix's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500 which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. Tonix's rare disease portfolio includes TNX-2900 (intranasal potentiated oxytocin) for the treatment of Prader-Willi syndrome. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.tonixpharma.com

Headquarters

Carson City, Nevada, USA

Founded

Tonix Pharmaceuticals Holding Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TNXP. The last closing price for Tonix Pharmaceuticals was US$0.61. Over the last year, Tonix Pharmaceuticals shares have traded in a share price range of US$ 0.118 to US$ 14.08.

Tonix Pharmaceuticals currently has 186,894,225 shares in issue. The market capitalisation of Tonix Pharmaceuticals is US$114.30 million. Tonix Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.98.

Form 8-K - Current report

Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia

Tonix received FDA’s Day 74 Letter granting TNX-102 SL a Prescription Drug User Fee Act (PDUFA) goal date of August 15, 2025 TNX-102 SL is a non-opioid, centrally acting analgesic, granted Fast...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.204	68.9189189189	0.296	1.3	0.2826	703239099	0.47390495	CS
4	0.3053	156.805341551	0.1947	1.3	0.1625	210877757	0.44063429	CS
12	0.3546	243.878954608	0.1454	1.3	0.118	92341699	0.36703254	CS
26	-0.81	-61.8320610687	1.31	1.31	0.118	55963548	0.35294793	CS
52	-12.3	-96.09375	12.8	14.08	0.118	29578129	0.60787417	CS
156	-78.92	-99.3704356585	79.42	958	0.118	15011749	44.79195674	CS
260	-215.5	-99.7685185185	216	958	0.118	15377921	109.66068473	CS

TNXP - Frequently Asked Questions (FAQ)

What is the current Tonix Pharmaceuticals share price?

The current share price of Tonix Pharmaceuticals is US$ 0.50

How many Tonix Pharmaceuticals shares are in issue?

Tonix Pharmaceuticals has 186,894,225 shares in issue

What is the market cap of Tonix Pharmaceuticals?

The market capitalisation of Tonix Pharmaceuticals is USD 114.3M

What is the 1 year trading range for Tonix Pharmaceuticals share price?

Tonix Pharmaceuticals has traded in the range of US$ 0.118 to US$ 14.08 during the past year

What is the PE ratio of Tonix Pharmaceuticals?

The price to earnings ratio of Tonix Pharmaceuticals is -0.98

What is the cash to sales ratio of Tonix Pharmaceuticals?

The cash to sales ratio of Tonix Pharmaceuticals is 14.66

What is the reporting currency for Tonix Pharmaceuticals?

Tonix Pharmaceuticals reports financial results in USD

What is the latest annual turnover for Tonix Pharmaceuticals?

The latest annual turnover of Tonix Pharmaceuticals is USD 7.77M

What is the latest annual profit for Tonix Pharmaceuticals?

The latest annual profit of Tonix Pharmaceuticals is USD -116.66M

What is the registered address of Tonix Pharmaceuticals?

The registered address for Tonix Pharmaceuticals is 769 BASQUE WAY, SUITE 300, CARSON CITY, NEVADA, 89706

What is the Tonix Pharmaceuticals website address?

The website address for Tonix Pharmaceuticals is www.tonixpharma.com

Which industry sector does Tonix Pharmaceuticals operate in?

Tonix Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
RELIReliance Global Group Inc	US$ 4.06 (238.33%)	31.63M
GTBPGT Biopharma Inc	US$ 4.95 (183.67%)	6.26M
RAPTRAPT Therapeutics Inc	US$ 1.53 (85.36%)	23.58M
ATPCAgape ATP Corporation	US$ 2.605 (79.66%)	3.98M
TRAWTraws Pharma Inc	US$ 8.81 (75.50%)	3.53M
AILEiLearningEngines Inc	US$ 0.5701 (-35.58%)	381.26k
HSDTHelius Medical Technologies Inc	US$ 0.6942 (-23.71%)	698.18k
CDTConduit Pharmaceuticals Inc	US$ 0.057 (-23.69%)	4.22M
WHLMWilhelmina International Inc	US$ 3.25 (-21.31%)	3.58k
CNTMConnectM Technology Solutions Inc	US$ 0.832 (-20.00%)	2.2k
EDBLEdible Garden AG Inc	US$ 0.4111 (72.95%)	47.77M
RELIReliance Global Group Inc	US$ 4.06 (238.33%)	31.63M
RIMEAlgorhythm Holdings Inc	US$ 0.0849 (11.13%)	28.52M
RAPTRAPT Therapeutics Inc	US$ 1.53 (85.36%)	23.58M
CYNCYNGN Inc	US$ 0.7293 (55.53%)	18.04M